SE‑Cluster

Search

Search markets, companies, evidence, and pages

TickerFTLF
SectorPackaged Foods
Mkt cap$90M
EV / EBITDA12.7×
PostureHigh Velocity
Composite70/100
LensTarget-side
SE-Cluster Research·Issuer Brief·Q2 2026CIK 1374328

Fitlife Brands, Inc.

FTLFHIGH VELOCITYFILING INTENSITY

Fitlife Brands, Inc. reads as High Velocity (composite 70/100); pressure / disclosure signals dominate the posture this cycle · primary market Consumer Products.

Lens

Disclosed M&A capital (2023–2025)

$79M

+999%

vs $500K in 2020–2022

Disclosed transactions

3

new

2/3 active fiscal years in window

Buyer archetype

Consistent Strategic Buyer

Meaningful spend appears across repeat years.

Composite score

70

/100

High Velocity dominates · Filing Intensity

Financial snapshot
Revenue$81M
EBITDA$11M
Enterprise value$133M
EV / Revenue1.6×
EV / EBITDA12.7×
P/EN/A
Cash$8M
Total debt$46M
as of 2026-05-10
§ I·SE-Cluster Issuer Brief

Behavioral posture, nine reads.

Each index scores the issuer 0–100 against an EDGAR-anchored definition. Scores ≥ threshold elevate the issuer into the index's constituent set; the dominant index drives the masthead label.

Active Acquirer

16/100

Companies actively deploying disclosed capital into M&A

  • $88M disclosed buyer spend

Buyer Cadence

16/100

Buyer-side companies with recent filing activity

  • Filed within 49d
  • 149 8-Ks

Target Probability

20/100

Issuers showing target-side patterns from filings

  • 8 activism filings

Spin/Carve

0/100

Issuers showing spin-off, carve-out, or sum-of-parts posture

  • 8 activism filings

Pressure Watch

20/100

Issuers facing activism, governance, or control pressure

  • 8 activism filings
  • Latest activism 6.4y ago; heavily discounted

Distress Watch

44/100

Issuers showing financial-distress filing patterns

  • 10-Q 208d stale
  • 8 activism filings

Restatement Risk

43/100

Issuers with accounting-integrity flags from filings

  • 1 non-reliance 8-K
  • 5 auditor changes
  • 13 NT late filings
  • Latest event 3.6y ago; discounted

Capital Velocity

Dominant
70/100

Issuers with the highest filing-activity intensity

  • 149 8-Ks
  • 5 form types

Quiet Power

0/100

Large issuers with low signal volume and clean disclosure cadence

  • Enterprise value $133M
  • 10-Q 208d ago
  • 3 active signals
§ II·SE-Cluster Issuer Brief

Capital cadence.

Ten-year disclosed M&A activity. Bars show spend ($MM); ticks show recorded transaction count. Disclosure tier annotated where v6 audited corpus carries an entry.

16
17
18
19
20
21
22
23
24
25

Disclosed spend $MM Disclosed transactions (right axis)Peak spend year: $43M · Peak count: 2

FYDisclosed buysDisclosed spendAvg ticketAudited tier
20251$43M$43MN/A
2024N/AN/AN/AN/A
20232$36M$18MN/A
2022N/A$500KN/AN/A
2021N/AN/AN/AN/A
2020N/AN/AN/AN/A
§ III·SE-Cluster Issuer Brief

Strategy posture.

The buyer's playbook in terms of strategic archetype: what each disclosed move says about how they're deploying capital.

Archetype mix

  • Bolt On
    50%
  • Geographic Expansion
    50%

Strategy keywords

Terms recurring across recent 10-K acquisition disclosures.

  • bolt_on
  • geographic_expansion
§ IV·SE-Cluster Issuer Brief

Filing language.

Direct excerpts from acquisition disclosures and strategy sections: the verbs the buyer chose, in the filings they signed.

The acquisition of MusclePharm had minimal impact on revenue due to (1) the transaction closing during the fourth quarter, (2) the need to procure inventory since only $195 of inventory was acquired in the asset purchase, and (3) the need to negotiate new commercial agreements with MusclePharm’s existing customers.

10-KFY2023

Effective January 1, 2009, the Company adopted a new accounting standard included in ASC 810, Consolidations (formerly SFAS 160, Noncontrolling Interests in Consolidated Financial Statements).

10-KFY2010

opportunity to complement existing operations of the Company and the opportunity to generate future synergies within the nutritional supplement and wellness business.

10-KFY2025

In June 2009, the FASB issued revised guidance on the accounting for variable interest entities.

10-KFY2010

The purchase was intended to augment and diversify the Company’s product offerings and lineup.

10-KFY2025
§ V·SE-Cluster Issuer Brief

Market context.

Where this issuer sits inside its SE-Cluster rollup wedge, with disclosed-spend rank plus trading comparables against the public peer set.

Primary market

Consumer Products

Market spend (2023–2025)
$145.2B
Market spend (2020–2022)
$102.1B
Recent vs prior
+42%
Issuer rank in market
N/A
Share of market capital
0.0%

Valuation positioning

12.7×EV / EBITDA

FTLF trades at a +0.5-turn premium to the Consumer Products peer median of 12.2×.

EV / Revenue
1.6×
Net debt / EBITDA
3.6×
Peer median EV / EBITDA
12.2×

Trading comparables

FMP market data · 2026-05-10

CompanyEV / EBITDAEV / RevNet debt / EBITDARevenueM&A 2023–2025
15.7×2.3×2.0×$164.7B$24.6B
Fitlife Brands, Inc.FTLF
12.7×1.6×3.6×$81M$79M
8.7×1.3×-0.1×$10B$5.5B

Trading multiples from FMP market data; disclosed M&A spend from the SE-Cluster EDGAR 10-K corpus. Peer set = top disclosed buyers in Consumer Products. Bars scaled to the highest EV/EBITDA in the set.

§ VI·SE-Cluster Issuer Brief

Buyer landscape.

Public buyers whose stated archetypes, target categories, and recent cadence align with this issuer as a plausible acquisition target. Scores cross EDGAR signal and disclosure overlap.

Likely buyers

No public buyers surface as a strong target-side fit on current signal.

Likely sellers / divestiture partners

No reciprocal divestiture / strategic-alternatives matches identified.

§ VII·SE-Cluster Issuer Brief

Filing activity & signal stream.

Filing cadence and event-driven signals visible on EDGAR. The signal stream below is curated from restatement / spin-carve / activism categories, providing context for any near-term call.

Filing cadence

  • 10-K (annual)252026-04-21
  • 10-Q (quarterly)542025-11-13
  • 8-K (event)1492026-04-07
  • Proxy / DEF 14A132025-06-24
  • Activism (13D / DFAN / PREC)82020-01-31

Signals on file

  • critical

    Non-reliance disclosure

    2022-09-21

    1 Item 4.02 filing on file; financial-statement non-reliance.

  • elevated

    Auditor change

    2022-10-18

    5 Item 4.01 filings on file; certifying accountant change.

  • watch

    Late-filing notice

    2022-05-16

    13 NT 10-K/10-Q filings on file.

  • elevated

    Activism on file

    2020-01-31

    8 activist filings on file (13D, DFAN14A, PREC14A series).

  • info

    Signal

    Serial acquisition history

  • info

    Signal

    10-K strategy themes

  • info

    Signal

    Restatement risk

§ VIII·SE-Cluster Issuer Brief

Audited corpus.

No audited record on file for this CIK in the current v6 corpus.

This issuer has not been extracted into the v6 audited acquirer corpus yet. The brief above pulls from ranking-level aggregates and issuer-index signal only.